Physician profile
Lance Scott
NPI 1417958059
$5,130.90
in general payments reported to CMS, 2019-2025
20 companies · $978 in 2025
The $978 reported for 2025 was more than what 77% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $510 · 2020: $276 · 2021: $338 · 2022: $746 · 2023: $1,162 · 2024: $1,119 · 2025: $978.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,259.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,259.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $839.60 | 2022-2025 | Byooviz |
| Regeneron Healthcare Solutions, INC. | $664.60 | 2019-2025 | Eylea Hd, Eylea |
| Apellis Pharmaceuticals, INC. | $590.89 | 2023-2025 | Syfovre |
| Genentech USA, INC. | $585.12 | 2020-2025 | Vabysmo |
| Coherus Oncology, INC. | $363.60 | 2023-2024 | |
| Alimera Sciences, INC. | $340.15 | 2019-2024 | Iluvien, Yutiq |
| Ani Pharmaceuticals, INC. | $295.67 | 2024-2025 | Iluvien, Yutiq, Purified Cortrophin Gel |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $273.17 | 2019-2021 | |
| Astellas Pharma US INC | $226.77 | 2023-2025 | Izervay |
| Abbvie INC. | $222.56 | 2022-2025 | Ozurdex |
| Sandoz INC. | $178.53 | 2024-2025 | Cimerli |
| Novartis Pharmaceuticals Corporation | $134.25 | 2019-2020 | |
| Mallinckrodt Enterprises LLC | $129.05 | 2019 | |
| Allergan, INC. | $125.77 | 2020 | |
| Carl Zeiss Meditec Ag | $38.80 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vyera Pharmaceuticals, LLC | $32.50 | 2019-2020 | |
| Bausch & Lomb Americas INC. | $24.43 | 2022 | |
| Heidelberg Engineering, INC. | $23.29 | 2022 | |
| Glaukos Corporation | $21.62 | 2022 | |
| Eyepoint US, INC. | $20.53 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lance Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.